Journal of medical Internet research

BMJ (Clinical research ed.)

[1] Results and Methodological Implications of the Digital Epidemiology of Prescription Drug References Among Twitter Users: Latent Dirichlet Allocation (LDA) Analyses.

[2] When I use a word . . . Medical slang: gomers and gomerettes.

[3] Genotoxicity of gold nanoparticles in the gilthead seabream (Sparus aurata) after single exposure and combined with the pharmaceutical gemfibrozil

[4] In vitro anti-neoplastic activity of the ethno-pharmaceutical plant Hypericum adenotrichum Spach endemic to Western Turkey.

[5] Combining Cellulose and Cyclodextrins: Fascinating Designs for Materials and Pharmaceutics.

[6] Supramolecular pharmaceutical sciences: A novel concept combining pharmaceutical sciences and supramolecular chemistry

[7] Generic selection criteria for safety and patient benefit [VIII]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic diclofenac sodium tapes.

[8] Possible use of a Nicotiana tabacum ‘Bright Yellow 2’ cell suspension as a model to assess phytotoxicity of pharmaceuticals (diclofenac)

[9] Heterogeneous Fenton-like oxidation of pharmaceutical diclofenac by a catalytic iron-oxide ceramic microfiltration membrane

[10] Removal of pharmaceuticals by powdered activated carbon adsorption: Effect of particle size and point of addition

[11] The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership

[12] Chemical profiling of Centaurea bornmuelleri Hausskn. aerial parts by HPLC-MS/MS and their pharmaceutical effects: From nature to novel perspectives.

[13] Extraction and determination of trace amounts of three anticancer pharmaceuticals in urine by three-phase hollow fiber liquid-phase microextraction based on two immiscible organic solvents followed by high-performance liquid chromatography.

[14] In Situ Characterization of Pharmaceutical Formulations by Dynamic Nuclear Polarization Enhanced MAS NMR.

[15] Study of the state of readiness of pharmaceutical institutions of Ukraine for implementation of integrated quality systems

[16] Research output of India compared to BRICS countries in publishing pharmacology, toxicology and pharmaceutics research papers

[17] [Practice Examples of Academic Detailing -Prescription Support Based on Basic Pharmaceutical Science and Evidence].

[18] Voltammetric Analysis of Cephalexin and Cefazoline in Pharmaceutical Formulation and Biological Samples

[19] Curcumin: Biological, Pharmaceutical, Nutraceutical, and Analytical Aspects

[20] Development and validation of an ecofriendly chemiluminescence method for the determination of citalopram in pharmaceutical preparations using Cu²+-grafted Oxidized multiwall carbon nanotubes

[21] Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases.

[22] From courts to markets: New evidence on enforcement of pharmaceutical bans in India.

[23] Human health risk assessment of pharmaceuticals in treated wastewater reused for non-potable applications in Sharjah, United Arab Emirates.

[24] An Exploration of Factors Affecting Deposition of Pharmaceutical Aerosols in the Alberta Idealized Throat.

[25] Home treatment and use of informal market of pharmaceutical drugs for the management of paediatric malaria in Cotonou, Benin.

[26] Application of the Discrete Element Method for Manufacturing Process Simulation in the Pharmaceutical Industry.

[27] Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016.

[28] Mechanisms of pharmaceutical and personal care product removal in algae-based wastewater treatment systems.

[29] Assessing the contribution of hydroxylation species in the photochemical transformation of primidone (pharmaceutical).

[30] A proposal for an alternative approach to particle size method development during early stage small molecule pharmaceutical development.

[31] Pharmaceutical Pill Counting and Inspection Using a Capacitive Sensor

[32] Seasonal and spatial variations of pharmaceuticals and personal care products occurrence and human health risk in drinking water - A case study of China.

[33] Concurrence of antibiotic resistant bacteria (ARB), viruses, pharmaceuticals and personal care products (PPCPs) in ambient waters of Guwahati, India: Urban vulnerability and resilience perspective.

[34] An evaluation on the intra-day dynamics, seasonal variations and removal of selected pharmaceuticals and personal care products from urban wastewater treatment plants

[35] Varying results of early benefit assessment of newly approved pharmaceutical drugs in Germany from 2011 to 2017: A study based on federal joint committee data.

[36] The structure of the pharmaceutical market in Iran using concentration indices.

[37] Direct UV photolysis of pharmaceutical compounds: Determination of pH-dependent quantum yield and full-scale performance

[38] Chitosan: An Update on Potential Biomedical and Pharmaceutical Applications

[39] Chitosan Modification and Pharmaceutical/Biomedical Applications

[40] Molecular, Cellular and Pharmaceutical Aspects of Biomaterials in Dentistry and Oral and Maxillofacial Surgery. An Internationalization of Higher Education and Research Perspective.

[41] Patent implications in the pharmaceutical industry: Are static high prices leading to dynamic innovations?

[42] Stone cutting industry waste-supported zinc oxide nanostructures for ultrasonic assisted decomposition of an anti-inflammatory non-steroidal pharmaceutical compound.

[43] A novel enzymatic microreactor: Towards transforming the pharmaceutical industry

[44] Toxicity of azo dyes in pharmaceutical industry

[45] Role of Robotic Process Automation in Pharmaceutical Industries

[46] Bioconjugation as a smart immobilization approach for α-amylase enzyme using stimuli-responsive Eudragit-L100 polymer: a robust biocatalyst for applications in pharmaceutical industry

[47] Strategy-making process and firm performance in Iranian pharmaceutical industry

[48] Evaluation of a Dry Coating Technology as a Substitute for Roller Compaction for Dry Agglomeration Applications in the Pharmaceutical Industry

[49] The Contact-Hitting R&D Strategy of Family Firms in the Japanese Pharmaceutical Industry

[50] Evaluation of pharmaceutical industry-led access programmes: A standardised framework

[51] Microfluidic process intensification for synthesis and formulation in the pharmaceutical industry

[52] Knowledge breadth and depth development through successful R&D alliance portfolio configuration: An empirical investigation in the pharmaceutical industry

[53] From small molecule generics to biosimilars: Technological upgrading and patterns of distinctive learning processes in the Indian pharmaceutical industry

[54] Stock market behavior of pharmaceutical industry in Iran and macroeconomic factors

[55] Political connections and strategic choices of emerging market firms: Case study of Russia’s pharmaceutical industry

[56] Association between medicine Price declaration by pharmaceutical industries and retail prices in Malaysia's private healthcare sector

[57] Determinants of intra-industry trade in pharmaceutical industry products. The case of the Czech republic and its eu trade partners

[58] Response of safety pharmacologists to challenges arising from the rapidly evolving changes in the pharmaceutical industry

[59] Modeling and Growth Kinetics of Antisolvent Crystallization Applied to the Pharmaceutical Industry

[60] Health Technology Assessment in Japan: A Pharmaceutical Industry Perspective

[61] Green Chemistry Articles of Interest to the Pharmaceutical Industry

[62] Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015

[63] Analysis of energy-related CO <inf>2</inf> emissions in China's pharmaceutical industry and its driving forces

[64] A qualitative approach to assess innovation in small infant industries within developing countries: The case of pharmaceuticals in Tunisia^†

[65] Does CSR matter in the pharmaceutical distribution industry?: The balanced scorecard perspective

[66] When risks need attention: adoption of green supply chain initiatives in the pharmaceutical industry

[67] Issues to consider in the pharmaceutical development of a cardiovascular polypill.

[68] Are traditional small-scale screening methods reliable to predict pharmaceutical spray drying?

[69] Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK.

[70] Pharmaceuticals and Medical Devices: Business Practices.

[71] The removal of pharmaceuticals during wastewater treatment: Can it be predicted accurately?

[72] Two Manganese Peroxidases and a Laccase of KU-RNW027 with Novel Properties for Dye and Pharmaceutical Product Degradation in Redox Mediator-Free System.

[73] Unveiling of Concealed Processes for the Degradation of Pharmaceutical Compounds by sp.

[74] Characterization of recombinant laccase from Trametes versicolor synthesized by Arxula adeninivorans and its application in the degradation of pharmaceuticals

[75] In silico Analysis for Laccase-mediated Bioremediation of the Emerging Pharmaceutical Pollutants

[76] Bioaccumulation behaviour of pharmaceuticals and personal care products in a constructed wetland.

[77] Novel Magnetic Carbon Nanotube-TiO <inf>2</inf> Composites for Solar Light Photocatalytic Degradation of Pharmaceuticals in the Presence of Natural Organic Matter

[78] Adsorptive potential of tassel activated carbon towards the removal of metformin hydrochloride from pharmaceutical effluent.

[79] Postgraduate Education in Pharmaceutical Medicine in Australia: Evaluation and Evolution to a Global Program Over 20 Years.

[80] Adherence of pharmaceutical advertisements in medical journals to FDA guidelines and content for safe prescribing.

[81] A review of the effect of pharmaceutical firm drug announcements on stock option pricing.

[82] The British Pharmacological Society's WDM Paton Memorial Lecture 2019: How doctors were informed about pharmaceutical products through advertising in the British Medical Journal from 1955/6 to 1985/6.

[83] Synergistic catalytic effect between ultrasound waves and pyrimidine-2,4-diamine-functionalized magnetic nanoparticles: Applied for synthesis of 1,4-dihydropyridine pharmaceutical derivatives.

[84] Trends in heroin and pharmaceutical-opioid related harms in Victoria, Australia up to 2018.

[85] Analysis of pharmaceutical impurities using multi-heartcutting 2D LC coupled with UV-charged aerosol MS detection.

[86] Consumer behaviour towards pharmaceutical products: a model development

[87] The impact of evidence from clinical trials on counselling for over-the-counter drugs: A national survey of pharmaceutical staff in German pharmacies.

[88] A Comparative Study on Different Pharmaceutical Industries and Proposing a Model for the Context of Iran.

[89] The impact of pharmaceutical marketing on market access, treatment coverage, pricing, and social welfare

[90] Proceed to the innovation in the pharmaceutical industry. The case of Spain

[91] Assessing Biopharmaceutical Company Experience with Patient-centric Initiatives.

[92] Self-Regulation in the Pharmaceutical Industry: The Exposure of Children and Adolescents to Erectile Dysfunction Commercials.

[93] First nationwide investigation and environmental risk assessment of 72 pharmaceuticals and personal care products from Sri Lankan surface waterways.

[94] Spectrophotometric determination of tranexamic acid in pharmaceutical bulk and dosage forms.

[95] Simple spectrofluorimetric methods for determination of veterinary antibiotic drug (apramycin sulfate) in pharmaceutical preparations and milk samples

[96] Pharmaceutical diversification via palladium oxidative addition complexes.

[97] Development of a highly efficient decontamination approach for ceftolozane in the pharmaceutical manufacturing environment.

[98] PLANTAGO OVATA: A COMPREHENSIVE REVIEW ON CULTIVATION, BIOCHEMICAL, PHARMACEUTICAL AND PHARMACOLOGICAL ASPECTS.

[99] Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.

[100] A novel pharmaceutical excipient: Coprecipitation of calcium and magnesium silicate using brine-seawater in date palm cellulose as an absorbing host

[101] A novel pharmaceutical excipient: Coprecipitation of calcium and magnesium silicate using brine-seawater in date palm cellulose as an absorbing host